Giá trị của cộng hưởng từ 1.5 Tesla trong phân loại giai đoạn và theo dõi điều trị ung thư cổ tử cung

MUC LUC

s'O 1021

-IRAN TRONG Dl/ONG,

PHAM HUNG TIEN,

TRAN QUANG TRUNG

•VUNHATDjNH,

NGUYI N TRXN CANH TUNG

•CHUTHjTHICT,

TON THI KIM THANH,

LETHOYQUVNH

•NGUYEN VAN Dl/dNG.

DINH VAN THANH

•LAI THANH THUY,

TRXNVIETTCI

•TRUONG TH! MAI HONG

•NGUYI N TH! HONG NHUNG,

TRUONG QUANG DAT

•PHiBJUITH! THU HIEN

=> Danh gia t^ lfi ting huyet ap cfia ngudi dan tCr 30 bjfii trd I6n tai 55

phudng Phuong Canh, quin Nam TCr Ligm, H i Noi n3m 2015

=> Kfit qua gan phlu thuat thay khdp hang ban phfin vdi dudng mfi 58

bgn ngoai trut tiep

=> Ket qua trj so nhan ap bang nhan ap Ite Icare fi tre em dufii 6 tufii 61

^ Danh gia cich xii tri tiiieu oi 6 san phu cfi thai > 37 tufin tai Benh 64

vien Da khoa huySn Ti§n Du tlnh Bic IMinh nim 2016

=> Nghien ciiiu nong dp B-Type Natriuretic Peptide (BNP) huyfit tUOng 67

d ttf nh nli3n xo gan

=5- Hpi chiing tifit tifit hpp W hormon chfing bii ni§u vfi hfii chCfng mfit 70

muoi nao trong nhiem Ichuan thfin Itinh cfip 6 tre em

=> Trigu chijfng roi loan man Itinh 6 phu nu" tai Nhon Phij - Quy Nhdn 73

nam 2015

=> Thut: trang benh siu ring, viSm ldi fi tre khuyfit tit tai l^ng Trfi 77

em Hfia Binh, Hi Nfii

GIA TR! CUA CONG HinTNG TUT 1.5 TESLA

TRONG PHAN LOAI GIAI DOAN VA THEO DOI DIEU TRI UNG THIT Cti TUT CUNG

TOIMTAT

M6 td tiSn ct>u 41 t4nh nhSn ung thu cfi td" cung

{BN UTCTC) cd diy dd kit qua giii phiu b^nh (GPB).

ffopc chup CHT 1.5 Tesla trudc vd sau DT. Kit qud:

Tuoi thip nhit 31, cao nhit 68. tmng blnh 47,8 ± 1.5.

UTMB vdy 80,5%, UTBM tuySn 14.6%. CHTtru^BT

xdc dinh chlnh xdc GD UTCTC, giiip cdc nhd LS xdc

dint) phdc d6 BT thich hgp. Sau BT95.1% c^uySn vi

GD thip hcm. tmng dd 65.9% chuySn vS GD 0'.

K4tlu$n: CHT 1.5Txic <3inh chlnh xdc GB UTCTC.

Chiu trich nhi$m: DoMn VSn Wgpc

Dja chi: Khoa Y Du^ - DHQGHN

Email: [email protected]

Ngay nh$n: 22/61/2016

Ngay phdn bi$n: 18/7/2016

Ngdy duy$t bdi: 04/8/2016

Ngdy xuit bdn: 20/9/2016

DOAN VAN NGOC, BUI VAN L§NH', BUI Dl|U'

^Khoa YDwiyc, Dai hgc Qufic gla Hd N^i

'Tririmg D^i hgc YHdN^i

^B§nh vl$n K Trung uvng

giup LS xdc djnh phdc dd DT thich hgp, ddnh gid hi$u

qud di dinh hudng cho LS tmng qud trlnh DT UTCTC.

TIP khda: Ung thw CTC. CHT.

Value of 1.5T MRI in the staging and monitoring

the treatment of cervical cancer

SUMIVIARY

A prospective study of 41 cervical cancer patients,

who have full pathology results, was had 1.5T liffll

before and after treatment Results: The mm and max

ages are 31 and 68, the average age is 47.8 ± 1.5.

Carcinoma epidermoide 80.5%, Admocarcir)otr\a

14.6%. MRI before treatment is useful for diagnose

periods of the disease accurately, helps clinicians

determine appropriate treatment regimens. After

treating had transferred 95.1% lower stage, while

65.9% moved to stage 0*. Conclusions. MRI 1.5T is

valuable in determining stage of cervical cancer

exactly, helps determine appropriate regimen for

effective treatment.

Keywords: Cervical cancer, MRL

Y HOC THirC HANH (1021) - S6 9/201f